AMP Horizons Series: The 2019 Novel Coronavirus Outbreak: What Laboratories Need to Know about the Virus, Epidemiology, and Diagnostic Testing
The current outbreak of 2019 novel Coronavirus (SARS-CoV-2) has the potential to evolve into a global pandemic. Molecular testing laboratories are fielding questions daily and clinical laboratory professionals are attempting to navigate questions about the virus as well as demands for diagnostic testing.
This AMP “Horizons in Molecular Pathology” webinar, sponsored and planned by the AMP Training and Education Committee, will address the laboratory and clinical considerations for the COVID-19 outbreak. Dr. Capraro will begin with an up-to-date overview of the biological characteristics of SARS-CoV-2 as well as current epidemiology. The status of laboratory testing, including the use of commercial assays, will also be discussed. Dr. Versalovic will present, from the perspective of a Laboratory Director, information on criteria for testing, navigating regulatory issues, and coordinating testing and care with laboratory personnel, the clinical team, and external stakeholders (e.g., the CDC and local public health departments). Dr. Graf will summarize and moderate a question and answer session.
- Describe the characteristics of SARS-CoV-2 biology and infection.
- Discuss current epidemiological data on the COVID-19 outbreak.
- Describe laboratory considerations for COVID-19 testing and reporting.
Gerald A. Capraro PhD, D(ABMM)
James Versalovic, MD, PhD
Erin Graf, PhD, D(ABMM)
Duration: 1 hr
Level of Instruction: Basic
Date Recorded: February 20, 2020
Planned and coordinated by the Training and Education Committee
Continuing Education Credit InformationCME credit: 1.0
CMLE credit: 1.0
Last day to claim credit: March 20, 2021
AMA PRA Category 1 Credit(s)™
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Note: Members of AMP can access this webinar at no cost. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.